| urban lymphatic filariasis in central nigeria. | wuchereria bancrofti and the other mosquito-borne parasites that cause human lymphatic filariasis (lf) infect over 120 million people world-wide. global efforts are underway to stop transmission of the parasites, using annual, single-dose mass drug administrations (mda) to all at-risk populations. although most mda to date have been in rural settings, they are also recommended in urban areas of transmission. it remains unclear whether there is significant urban transmission in west africa, howev ... | 2006 | 16492364 |
| evidence for stopping mass drug administration for lymphatic filariasis in some, but not all local government areas of plateau and nasarawa states, nigeria. | an average of six annual rounds of ivermectin and albendazole were distributed in plateau and nasarawa states, nigeria, to eliminate lymphatic filariasis. from 2007 to 2008, population-based surveys were implemented in all 30 local government areas (lgas) of the two states to determine the prevalence of wuchereria bancrofti antigenemia to assess which lga mass drug administration (mda) could be halted. in total, 36,681 persons from 7,819 households were examined for filarial antigen as determine ... | 0 | 22855758 |
| epidemiological and entomological evaluations after six years or more of mass drug administration for lymphatic filariasis elimination in nigeria. | the current strategy for interrupting transmission of lymphatic filariasis (lf) is annual mass drug administration (mda), at good coverage, for 6 or more years. we describe our programmatic experience delivering the mda combination of ivermectin and albendazole in plateau and nasarawa states in central nigeria, where lf is caused by anopheline transmitted wuchereria bancrofti. baseline lf mapping using rapid blood antigen detection tests showed mean local government area (lga) prevalence of 23% ... | 2011 | 22022627 |